When is crossover desirable in cancer drug trials and when is it problematic?. (10th April 2018)

Record Type:: Journal Article
Title:: When is crossover desirable in cancer drug trials and when is it problematic?. (10th April 2018)
Main Title:: When is crossover desirable in cancer drug trials and when is it problematic?
Authors:: Haslam, A
Prasad, V
Abstract:
Is Part Of:: Annals of oncology. Volume 29:Number 5(2018)
Journal:: Annals of oncology
Issue:: Volume 29:Number 5(2018)
Issue Display:: Volume 29, Issue 5 (2018)
Year:: 2018
Volume:: 29
Issue:: 5
Issue Sort Value:: 2018-0029-0005-0000
Page Start:: 1079
Page End:: 1081
Publication Date:: 2018-04-10
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy116 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16510.xml